Jet Capital Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVD
COVANCE INC.
CVD
|
+$96.1M |
| 2 |
AGN
Allergan Inc
AGN
|
+$82.5M |
| 3 |
BHI
Baker Hughes
BHI
|
+$67.7M |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$55.4M |
| 5 |
Zoetis
ZTS
|
+$53.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$105M |
| 2 |
Pfizer
PFE
|
+$102M |
| 3 |
HES
Hess
HES
|
+$81M |
| 4 |
Herc Holdings
HRI
|
+$66.7M |
| 5 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.7% |
| 2 | Healthcare | 13.04% |
| 3 | Utilities | 12.03% |
| 4 | Consumer Discretionary | 5.87% |
| 5 | Consumer Staples | 4.22% |
Similar funds
Jet Capital Investors's Q4 2014 Portfolio in Review
As of Q4 2014, Jet Capital Investors held 77 positions worth $2.72B, up 0.26% from $2.71B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Jet Capital Investors withdrew a net $451M in Q4 2014, closing 28 positions and reducing 9 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 38% a quarter earlier, followed by Healthcare and Utilities.
Against the trend, Jet Capital Investors opened a new position in COVANCE INC. worth $106M.
- Jet Capital Investors's largest Q4 2014 buy was COVANCE INC.: 1,025,000 shares worth $106M.
- Jet Capital Investors added most to Allergan Inc in Q4 2014, an estimated $82.5M increase.
- Jet Capital Investors's biggest Q4 2014 reduction was B/E Aerospace Inc, cutting an estimated $56.7M.
- Jet Capital Investors fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $105M.
- Jet Capital Investors's ten largest holdings make up 53% of its $2.72B portfolio in Q4 2014.
- Jet Capital Investors opened 30 new positions and closed 28 in Q4 2014.
- Jet Capital Investors's portfolio value rose 0.26% quarter-over-quarter to $2.72B.
Based on Jet Capital Investors's 13F filing for Q4 2014, filed 17 Feb 2015.